Page 97 - Read Online
P. 97

Page 18 of 20          Nakamura et al. Mini-invasive Surg 2022;6:50  https://dx.doi.org/10.20517/2574-1225.2022.38

               21.      Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic
                   submucosal dissection for gastric neoplasms. Gastrointest Endosc 2013;78:476-83.  DOI  PubMed
               22.      Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric
                   neoplasms? Gastrointest Endosc 2012;75:719-27.  DOI  PubMed
               23.      Miyahara K, Iwakiri R, Shimoda R, et al. Perforation and postoperative bleeding of endoscopic submucosal dissection in gastric
                   tumors: analysis of 1190 lesions in low- and high-volume centers in Saga, Japan. Digestion 2012;86:273-80.  DOI  PubMed
               24.      Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal
                   dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 2012;27:907-12.  DOI  PubMed
               25.      Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum:
                   complication rates and long-term outcomes. Surg Endosc 2013;27:1000-8.  DOI  PubMed  PMC
               26.      Kim TS, Kim B, Min BH, et al. Outcomes of endoscopic submucosal dissection for intestinal-type adenocarcinoma with anastomosing
                   glands of the stomach. J Gastroenterol Hepatol 2020;35:50-5.  DOI  PubMed
               27.      Nam HS, Choi CW, Kim SJ, et al. Risk factors for delayed bleeding by onset time after endoscopic submucosal dissection for gastric
                   neoplasm. Sci Rep 2019;9:2674.  DOI  PubMed  PMC
               28.      Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from
                   ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol
                   2007;102:1610-6.  DOI  PubMed
               29.      Libânio D, Costa MN, Pimentel-Nunes P, Dinis-Ribeiro M. Risk factors for bleeding after gastric endoscopic submucosal dissection: a
                   systematic review and meta-analysis. Gastrointest Endosc 2016;84:572-86.  DOI  PubMed
               30.      Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer:
                   BEST-J score. Gut 2021;70:476-84.  DOI  PubMed  PMC
               31.      Toya Y, Endo M, Sugai K, et al. Protective effect of proton pump inhibitors and potassium competitive acid blockers against post-
                   gastric endoscopic submucosal dissection bleeding: a single-center, propensity score-matched analysis. Scand J Gastroenterol
                   2021;56:199-204.  DOI  PubMed
               32.      Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced
                   gastric ulcers: a prospective randomized phase II study. J Gastroenterol 2019;54:122-30.  DOI  PubMed
               33.      Kakushima N, Ono H, Takizawa K, et al. Incidence of delayed bleeding among patients continuing antithrombotics during gastric
                   endoscopic submucosal dissection. Intern Med 2019;58:2759-66.  DOI  PubMed  PMC
               34.      Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J
                   Gastroenterol 2021;56:640-50.  DOI  PubMed
               35.      Fujimoto K, Fujishiro M, Kato M, et al; Japan Gastroenterological Endoscopy Society. Guidelines for gastroenterological endoscopy
                   in patients undergoing antithrombotic treatment. Dig Endosc 2014;26:1-14.  DOI  PubMed
               36.      Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral
                   anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
                   Endoscopy 2016;48:385-402.  DOI  PubMed
               37.      Acosta RD, Abraham NS, Chandrasekhara V, et al; ASGE Standards of Practice Committee. The management of antithrombotic
                   agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016;83:3-16.  DOI  PubMed
               38.      Dong J, Wei K, Deng J, et al. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. Gastrointest
                   Endosc 2017;86:807-16.  DOI  PubMed
               39.      Jaruvongvanich V, Sempokuya T, Wijarnpreecha K, Ungprasert P. Continued versus interrupted aspirin use and bleeding risk after
                   endoscopic submucosal dissection of gastric neoplasms: a meta-analysis. Ann Gastroenterol 2018;31:344-9.  DOI  PubMed  PMC
               40.      Tomida H, Yoshio T, Igarashi K, et al; FIGHT-Japan Study Group. Influence of anticoagulants on the risk of delayed bleeding after
                   gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric Cancer 2021;24:179-89.  DOI  PubMed
               41.      Kato M, Uedo N, Hokimoto S, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment:
                   2017 appendix on anticoagulants including direct oral anticoagulants. Dig Endosc 2018;30:433-40.  DOI  PubMed
               42.      Igarashi K, Takizawa K, Kakushima N, et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic
                   submucosal dissection? Surg Endosc 2017;31:1746-53.  DOI  PubMed
               43.      Yoshio T, Nishida T, Kawai N, et al. Gastric ESD under heparin replacement at high-risk patients of thromboembolism is technically
                   feasible but has a high risk of delayed bleeding: Osaka university ESD study group. Gastroenterol Res Pract 2013;2013:365830.  DOI
                   PubMed  PMC
               44.      Furuhata T, Kaise M, Hoteya S, et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving
                   antithrombotic therapy. Gastric Cancer 2017;20:207-14.  DOI  PubMed
               45.      Yoshio T, Tomida H, Iwasaki R, et al. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic
                   submucosal dissection. Dig Endosc 2017;29:686-94.  DOI  PubMed
               46.      Gotoda T, Hori K, Iwamuro M, et al. Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic
                   submucosal dissection. Endosc Int Open 2017;5:E653-62.  DOI  PubMed  PMC
               47.      Sanomura Y, Oka S, Tanaka S, et al. Taking warfarin with heparin replacement and direct oral anticoagulant is a risk factor for
                   bleeding after endoscopic submucosal dissection for early gastric cancer. Digestion 2018;97:240-9.  DOI  PubMed
               48.      Shindo Y, Matsumoto S, Miyatani H, Yoshida Y, Mashima H. Risk factors for postoperative bleeding after gastric endoscopic
   92   93   94   95   96   97   98   99   100   101   102